Fig. 1
From: Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma
MYH9 is increased in glioma and correlates with poor prognosis of glioma. (A) MYH9 mRNA expression in glioma tissues and para-tumor tissues among the glioma patients obtained from the TCGA database. (B) MYH9 protein level in glioma tissues and para-tumor tissues among the glioma patients obtained from the CPTAC database. (C, D) Kaplan–Meier survival analysis for overall survival (C) and Disease Free survival (D) based on the MYH9 expression data. (E) Western blot of MYH9 protein level in 3 glioma tissues and 3 para-tumor tissues. (F) The expression of MYH9 in tumor and adjacent samples were monitored by immunohistochemistry. (G) Representative images of MYH9 staining in (grade I-IV) glioma tissues (scale bar: 50 μm). Data are presented as the mean ± SD for three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001